(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(3.75%) $85.83
(1.42%) $1.782
(0.94%) $2 420.50
(1.18%) $28.72
(0.09%) $955.40
(0.25%) $0.942
(0.34%) $11.08
(0.33%) $0.807
(0.05%) $93.95
Live Chart Being Loaded With Signals
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology...
Stats | |
---|---|
Today's Volume | 23 707.00 |
Average Volume | 223 840 |
Market Cap | 5.01M |
EPS | $0 ( 2024-04-17 ) |
Next earnings date | ( $0 ) 2024-07-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0.330 |
ATR14 | $0.0110 (1.90%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-16 | Miller Josh | Sell | 46 | Common Stock |
2024-02-29 | Dgp Co., Ltd. | Sell | 3 400 000 | Common Stock |
2023-11-16 | Miller Josh | Sell | 38 | Common Stock |
2023-09-26 | Eom Minhee | Buy | 0 | |
2023-08-21 | Ko Hyuk Joon | Buy | 0 |
INSIDER POWER |
---|
-64.53 |
Last 81 transactions |
Buy: 16 542 799 | Sell: 13 981 621 |
Volume Correlation
Exicure Inc Correlation
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Exicure Inc Correlation - Currency/Commodity
Exicure Inc Financials
Annual | 2022 |
Revenue: | $28.83M |
Gross Profit: | $26.97M (93.56 %) |
EPS: | $-0.560 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-412 000 (0.00 %) |
EPS: | $-0.680 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-431 000 (0.00 %) |
EPS: | $-0.700 |
Q4 | 2022 |
Revenue: | $21.77M |
Gross Profit: | $21.32M (97.90 %) |
EPS: | $3.70 |
Financial Reports:
No articles found.
Exicure Inc
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators